My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0497
    CAS No. (CAS Registry Number): 557795-19-4
    Description: Sunitinib (formerly also known as SU11248; trade name: Sutent)  is a potent, orally bioavailable and multi-targeted RTK (receptor tyrosine kinase) inhibitor with potential antitumor ...
    Catalog No: V0498
    CAS No. (CAS Registry Number): 915769-50-5
    Description: Dovitinib Lactate (formerly TKI-258 lactate; CHIR-258 lactate), a benzimidazole-quinolinone analog, is a potent, orally bioavailable and multitargeted RTK inhibitor with potenti...
    Catalog No: V0499
    CAS No. (CAS Registry Number): 1254473-64-7
    Description: LY2874455 (LY-2874455; LY 2874455) is a novel and highly potent pan-FGFR inhibitor with potential anticancer activity. It inhibits FGFR1, FGFR2, FGFR3, and FGFR4 with IC50 value...
    Catalog No: V0500
    CAS No. (CAS Registry Number): 1225451-84-2
    Description: SKLB1002 (SKLB-1002; SKLB 1002) is a novel, potent and ATP-competitive VEGFR2 (VEGF receptor 2) inhibitor with potential antitumor activity. It inhibits VEGFR2 with an  IC50 of 32 nM...
    Catalog No: V0501
    CAS No. (CAS Registry Number): 1174046-72-0
    Description: BMS-794833 (BMS794833; BMS 794833) is an ATP competitive multi-kinase (Met/VEGFR2) inhibitor with potential anticancer activity. It inhibits Met/VEGFR2 with IC50s of 1.7 nM and 15 nM...
    Catalog No: V0502
    CAS No. (CAS Registry Number): 228559-41-9
    Description: Ki8751 (Ki-8751), a quinolyloxyphenyl-urea analog, is a novel, cell-permeable and selective inhibitor of VEGFR2 (Flk-1) with potential anticancer activity. I...
    164页次3/28首页<12345678910...>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved